Pfizer
PFE
PFE
2,200 hedge funds and large institutions have $152B invested in Pfizer in 2018 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 819 increasing their positions, 1,047 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,200
Holders Change
-25
Holders Change %
-1.12%
% of All Funds
50.44%
Holding in Top 10
176
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-2.22%
% of All Funds
4.03%
New
80
Increased
819
Reduced
1,047
Closed
83
Calls
$911M
Puts
$961M
Net Calls
-$49.8M
Net Calls Change
-$50.1M
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
$1.46B |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
$311M |
| 3 |
Two Sigma Advisers
New York
|
$144M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.93B |
| 5 |
State Street
Boston,
Massachusetts
|
$10.4B |
